The American Psychiatric Association's DSM Future Strategy Committee detailed new goals for the next iteration of the diagnostic manual. This information was published by the American Journal of Psychiatry. The FDA is currently reviewing a non-stimulant drug for the treatment of ADHD. The article mentions that 10 million people use microdosing. Dozens of mental health experts provided statements to the New York Times. These topics are part of the latest knowledge in the field of psychiatry.